Skip to content
About
Clinical Trials
Resources
Contact
About
Clinical Trials
Resources
Contact
LS-P-Lasso
LS-P-Lasso: A phase I study of bispecific antibody targeting PD-1 and TGFbR2 for solid tumors (INCA33890)
Status:
Open
Trial Type:
Early Phase Trials for Multiple Cancer Types
Contact:
Benedito Carneiro, MD
Benedito.carneiro@brownhealth.org